Metabolic disturbances in patients with paranoid schizophrenia treated with atypical antipsychotic drugs
Цель. Изучение влияния терапии классическими и атипичными антипсихотическими препаратами (АА) на динамику толерантности к глюкозе и некоторых показателей липидного обмена. Материалы и методы. Обследовано 50 больных с развившимся впервые в жизни психотическим эпизодом, отвечающим критериям па- раноид...
Saved in:
Main Authors: | Leonid Mikhaylovich Bardenshteyn, Ashot Musaelovich Mkrtumyan, Galina Andreevna Aleshkina |
---|---|
Format: | article |
Language: | EN RU |
Published: |
Endocrinology Research Centre
2010
|
Subjects: | |
Online Access: | https://doaj.org/article/5ca8c5be432442b883988bb4a00786ff |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
by: Ping Yin, et al.
Published: (2021) -
Antipsychotics and risk of natural death in patients with schizophrenia
by: Chen Y, et al.
Published: (2019) -
Association between IL-6 and metabolic syndrome in schizophrenia patients treated with second-generation antipsychotics
by: Fang X, et al.
Published: (2019) -
Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review
by: Xu H, et al.
Published: (2019) -
Second-generation long-acting injectable antipsychotics in schizophrenia: patient functioning and quality of life
by: Montemagni C, et al.
Published: (2016)